Literature DB >> 32589577

Breast Cancer: Lifestyle, the Human Gut Microbiota/Microbiome, and Survivorship.

Balazs I Bodai1, Therese E Nakata1.   

Abstract

Patients with a current diagnosis of breast cancer are enjoying dramatic cure rates and survivorship secondary to an increase in awareness, earlier detection, and more effective therapies. Although strategies such as Breast Cancer Awareness Month in October focus on early detection, lifestyle changes are seldom discussed other than dietary concerns and physical activity. Lifestyle modifications centered on diet and exercise have been demonstrated to affect overall disease-free survival in breast cancer. Since the early 2000s, the role of the human gut microbiota and its relation to breast cancer has become a major area of interest in the scientific and medical community. We live and survive owing to the symbiotic relationship with the microorganisms within us: the human microbiota. Scientific advances have identified a subset of the gut microbiota: the estrobolome, those bacteria that have the genetic capability to metabolize estrogen, which plays a key role in most breast cancers. Recent research provides evidence that the gut microbiome plays a substantial role in estrogen regulation. Gut microbiota diversity appears to be an essential component of overall health, including breast health. Future research attention should include a more extensive focus on the role of the human gut microbiota in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32589577      PMCID: PMC7319098          DOI: 10.7812/TPP/19.129

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  234 in total

1.  Diet, cancer, and NCD prevention.

Authors:  Michael Marmot
Journal:  Lancet Oncol       Date:  2018-05-24       Impact factor: 41.316

Review 2.  Minireview: Gut microbiota: the neglected endocrine organ.

Authors:  Gerard Clarke; Roman M Stilling; Paul J Kennedy; Catherine Stanton; John F Cryan; Timothy G Dinan
Journal:  Mol Endocrinol       Date:  2014-06-03

3.  Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update.

Authors:  Harold J Burstein; Sarah Temin; Holly Anderson; Thomas A Buchholz; Nancy E Davidson; Karen E Gelmon; Sharon H Giordano; Clifford A Hudis; Diana Rowden; Alexander J Solky; Vered Stearns; Eric P Winer; Jennifer J Griggs
Journal:  J Clin Oncol       Date:  2014-05-27       Impact factor: 44.544

4.  Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study.

Authors:  Zhao Chen; Michael Maricic; Tamsen L Bassford; Mary Pettinger; Cheryl Ritenbaugh; Ana Maria Lopez; David H Barad; Margery Gass; Meryl S Leboff
Journal:  Arch Intern Med       Date:  2005-03-14

Review 5.  Relevance of protein fermentation to gut health.

Authors:  Karen Windey; Vicky De Preter; Kristin Verbeke
Journal:  Mol Nutr Food Res       Date:  2011-11-25       Impact factor: 5.914

6.  Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

Authors:  J M Harvey; G M Clark; C K Osborne; D C Allred
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

Review 7.  Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue.

Authors:  R Cancello; K Clément
Journal:  BJOG       Date:  2006-08-10       Impact factor: 6.531

Review 8.  Venous thromboembolism in malignancy and malignancy in venous thromboembolism.

Authors:  F R Rickles; M N Levine
Journal:  Haemostasis       Date:  1998

Review 9.  Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction.

Authors:  Fumiaki Imamura; Laura O'Connor; Zheng Ye; Jaakko Mursu; Yasuaki Hayashino; Shilpa N Bhupathiraju; Nita G Forouhi
Journal:  BMJ       Date:  2015-07-21

10.  Extensive impact of non-antibiotic drugs on human gut bacteria.

Authors:  Lisa Maier; Mihaela Pruteanu; Michael Kuhn; Georg Zeller; Anja Telzerow; Exene Erin Anderson; Ana Rita Brochado; Keith Conrad Fernandez; Hitomi Dose; Hirotada Mori; Kiran Raosaheb Patil; Peer Bork; Athanasios Typas
Journal:  Nature       Date:  2018-03-19       Impact factor: 49.962

View more
  3 in total

1.  Microbiome composition indicate dysbiosis and lower richness in tumor breast tissues compared to healthy adjacent paired tissue, within the same women.

Authors:  Maria Valeria Esposito; Bruno Fosso; Marcella Nunziato; Graziano Pesole; Francesco Salvatore; Giorgio Casaburi; Valeria D'Argenio; Alessandra Calabrese; Massimiliano D'Aiuto; Gerardo Botti
Journal:  BMC Cancer       Date:  2022-01-03       Impact factor: 4.430

2.  Staphylococcus aureus-Derived Extracellular Vesicles Enhance the Efficacy of Endocrine Therapy in Breast Cancer Cells.

Authors:  Jeongshin An; Hyungju Kwon; Woosung Lim; Byung-In Moon
Journal:  J Clin Med       Date:  2022-04-05       Impact factor: 4.241

Review 3.  Drug Metabolism for the Identification of Clinical Biomarkers in Breast Cancer.

Authors:  Bárbara Costa; Nuno Vale
Journal:  Int J Mol Sci       Date:  2022-03-16       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.